Characterization and Sequencing of Duplex siRNA Using the BioAccord™ LC-MS System and Vion IMS QTof Mass Spectrometer in Combination With the waters_connect™ CONFIRM Sequence App
Applications | 2025 | WatersInstrumentation
Small interfering RNA (siRNA) has emerged as a transformative therapeutic modality in gene therapy and oncology. Ensuring precise sequence integrity, structural fidelity and high purity of duplex siRNA is critical to avoid off-target effects and maintain safety and efficacy standards. Advanced analytical workflows that integrate chromatographic separation, mass spectrometric detection and automated data processing are therefore essential for both research and regulated quality control applications.
This work demonstrates a streamlined LC-MS strategy that exploits controlled column temperature and complementary mass spectrometric modes to:
Duplexes were prepared by annealing equimolar sense and antisense strands. Ion-pair reversed-phase chromatography (IP-RP) separations were performed at 25 °C (non-denaturing) and 60 °C (denaturing). Mass spectrometry modes included:
At 25 °C, the duplex remains intact on column but dissociates in the electrospray, allowing strand-specific deconvolution. The INTACT Mass App identified co-eluting species with high mass accuracy (< 10 ppm) and reported combined LC×MS purity (~90%). At 60 °C, on-column denaturation produced baseline separation of sense and antisense strands, eliminating chimeric fragment overlaps in MSE data. Under denaturing conditions, the CONFIRM Sequence App achieved 100% sequence coverage for both strands, whereas non-denaturing runs provided ~90% due to overlapping fragment ions. Targeted MS/MS on the Vion IMS QTof also delivered full sequence confirmation, underscoring the complementarity of data-independent and targeted approaches.
This dual-temperature LC-MS approach offers:
Emerging advances in automation, high-resolution separations and ion mobility integration will further enhance oligonucleotide analysis throughput and accuracy. Expanded informatics capabilities, including machine-learning-driven spectral interpretation and real-time cloud reporting, will streamline regulatory compliance and accelerate therapeutic development across diverse oligonucleotide modalities.
The combined use of controlled column temperature, MSE fragmentation and targeted MS/MS provides a robust, automated solution for duplex siRNA characterization and sequencing. Leveraging the BioAccord and Vion IMS QTof platforms with waters_connect informatics enables precise purity measurements and full sequence confirmation within a streamlined, compliance-ready workflow.
LC/HRMS, LC/MS, LC/MS/MS, LC/TOF, Ion Mobility
IndustriesPharma & Biopharma
ManufacturerWaters
Summary
Significance of the Topic
Small interfering RNA (siRNA) has emerged as a transformative therapeutic modality in gene therapy and oncology. Ensuring precise sequence integrity, structural fidelity and high purity of duplex siRNA is critical to avoid off-target effects and maintain safety and efficacy standards. Advanced analytical workflows that integrate chromatographic separation, mass spectrometric detection and automated data processing are therefore essential for both research and regulated quality control applications.
Objectives and Study Overview
This work demonstrates a streamlined LC-MS strategy that exploits controlled column temperature and complementary mass spectrometric modes to:
- Maintain or denature duplex siRNA molecules on-column by adjusting temperature
- Evaluate duplex and single-strand purity and identity within a single run
- Obtain comprehensive sequence confirmation through automated informatics tools
Methodology and Instrumentation
Duplexes were prepared by annealing equimolar sense and antisense strands. Ion-pair reversed-phase chromatography (IP-RP) separations were performed at 25 °C (non-denaturing) and 60 °C (denaturing). Mass spectrometry modes included:
- Data-independent MSE fragmentation on the BioAccord LC-MS System, comprising an ACQUITY UPLC Premier I-Class PLUS, Tunable UV detector and RDa ESI-TOF detector
- Targeted MS/MS on a Vion IMS QTof instrument with precursor selection
Main Results and Discussion
At 25 °C, the duplex remains intact on column but dissociates in the electrospray, allowing strand-specific deconvolution. The INTACT Mass App identified co-eluting species with high mass accuracy (< 10 ppm) and reported combined LC×MS purity (~90%). At 60 °C, on-column denaturation produced baseline separation of sense and antisense strands, eliminating chimeric fragment overlaps in MSE data. Under denaturing conditions, the CONFIRM Sequence App achieved 100% sequence coverage for both strands, whereas non-denaturing runs provided ~90% due to overlapping fragment ions. Targeted MS/MS on the Vion IMS QTof also delivered full sequence confirmation, underscoring the complementarity of data-independent and targeted approaches.
Benefits and Practical Applications
This dual-temperature LC-MS approach offers:
- Comprehensive assessment of duplex purity, identity and sequence in one analysis
- Automated, compliance-ready workflows accessible to non-expert users
- Seamless integration into development, manufacturing and quality control environments
Future Trends and Opportunities
Emerging advances in automation, high-resolution separations and ion mobility integration will further enhance oligonucleotide analysis throughput and accuracy. Expanded informatics capabilities, including machine-learning-driven spectral interpretation and real-time cloud reporting, will streamline regulatory compliance and accelerate therapeutic development across diverse oligonucleotide modalities.
Conclusion
The combined use of controlled column temperature, MSE fragmentation and targeted MS/MS provides a robust, automated solution for duplex siRNA characterization and sequencing. Leveraging the BioAccord and Vion IMS QTof platforms with waters_connect informatics enables precise purity measurements and full sequence confirmation within a streamlined, compliance-ready workflow.
References
- Al Shaer D, Al Musaimi O, Albericio F, de la Torre BG. 2022 FDA TIDES Harvest. Pharmaceuticals. 15(2):222.
- Rossi JJ, Rossi DJ. siRNA Drugs: Here to Stay. Molecular Therapy. 29(2):431–432.
- Gilar M, Koshel BM, Birdsall RE. Ion-Pair RP and HILIC Methods for Oligonucleotides. Journal of Chromatography A. 1712:464475.
- Donegan M, Nguyen JM, Gilar M. Effect of Ion-Pairing Reagent Hydrophobicity on Oligonucleotide LC-MS. Journal of Chromatography A. 1666:462860.
- Abdullah AM, Sommers C, Hawes J, Rodriguez JD, Yang K. Tandem Mass Spectrometric Sequencing of Thymidine-Rich Oligonucleotides. Journal of Mass Spectrometry. 57(4):e4819.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Expanding the Antibody-Oligo Conjugate (AOC) Characterization Toolbox: Part 2- Denaturing and Non-denaturing Analysis of siRNA Payload
2025|Waters|Applications
Application Note Expanding the Antibody-Oligo Conjugate (AOC) Characterization Toolbox: Part 2Denaturing and Non-denaturing Analysis of siRNA Payload Samantha Ippoliti, Ying Qing Yu, Connor Brandenburg, Tara MacCulloch Waters Corporation, United States Note: This is the second application note in a three-part…
Key words
sirna, sirnapayload, payloaddenaturing, denaturinganalysis, analysislinker, linkeracquity, acquityaoc, aocpremier, premieriprp, iprpoligonucleotide, oligonucleotideintact, intactnon, nonapp, appoligonucleotides, oligonucleotidesconditions
Comprehensive LC-MS Analytical Assays for Antibody-Oligonucleotide Conjugate (AOC) and siRNA Linker-Payload Characterization
2025|Waters|Posters
Comprehensive LC-MS Analytical Assays for Antibody-Oligonucleotide Conjugate (AOC) and siRNA Linker-Payload Characterization Samantha Ippoliti1; Brad Williams1; Ying Qing Yu1; Connor Brandenburg; Tara MacCulloch; Michelle Chen2; Sophia Kenrick2 1 Waters Corporation, Milford, MA; 2Waters Corporation, Goleta, California INTRODUCTION METHODS Antibody-oligo conjugates…
Key words
sirna, sirnadenaturing, denaturingmcc, mccmab, mabaocs, aocsfree, freeaoc, aoclinker, linkerstrand, strandcharacterization, characterizationconjugate, conjugatesense, sensenon, nonantibody, antibodybioaccordtm
A Xevo™ G3-based Workflow for Purity Determination, Intact Mass Measurement, and MS/MS Sequencing of Impurities Detected in Synthetic Oligonucleotides
2024|Waters|Applications
Application Note A Xevo™ G3-based Workflow for Purity Determination, Intact Mass Measurement, and MS/MS Sequencing of Impurities Detected in Synthetic Oligonucleotides Catalin E. Doneanu, Jonathan Fox, Brad J. Williams, Chris Knowles, Ying Qing Yu Waters Corporation Abstract This study evaluates…
Key words
oligonucleotides, oligonucleotidesimpurities, impuritiessynthetic, syntheticdetected, detectedoligonucleotide, oligonucleotideapp, appsequence, sequencemse, mseconfirm, confirmpremier, premieroligo, oligouplc, uplcannotation, annotationspectra, spectramass
Reversed-Phase Ion-Pair LC/MS Analysis of siRNA under Denaturing and Non-Denaturing Conditions
2025|Shimadzu|Applications
Liquid Chromatograph Mass Spectrometer LCMS-9050 Application News Reversed-Phase Ion-Pair LC/MS Analysis of siRNA under Denaturing and Non-Denaturing Conditions Junna Nakazono User Benefits The LCMS-9050 quadrupole time-of-flight mass spectrometer can be used to characterize siRNA. The elution of siRNA…
Key words
denaturing, denaturingsirna, sirnaantisense, antisenseoligonucleotide, oligonucleotidesense, senseinquiry, inquirystranded, strandedbiologics, biologicsduplex, duplexnon, nonunder, underlabsolutions, labsolutionsnexera, nexerainsight, insightdenatured